These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18385303)

  • 1. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Brito EC; Franks PW
    J Appl Physiol (1985); 2008 Apr; 104(4):1248. PubMed ID: 18385303
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Pescatello LS
    J Appl Physiol (1985); 2008 Apr; 104(4):1247. PubMed ID: 18385302
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Timmons JA
    J Appl Physiol (1985); 2008 Apr; 104(4):1250. PubMed ID: 18385305
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Lightfoot JT
    J Appl Physiol (1985); 2008 Apr; 104(4):1249. PubMed ID: 18385304
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Thomis M
    J Appl Physiol (1985); 2008 Apr; 104(4):1251. PubMed ID: 18385306
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Wagner PD
    J Appl Physiol (1985); 2008 Apr; 104(4):1246. PubMed ID: 18385301
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Hawley JA
    J Appl Physiol (1985); 2008 Apr; 104(4):1253. PubMed ID: 18385308
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Wolfarth B
    J Appl Physiol (1985); 2008 Apr; 104(4):1252. PubMed ID: 18385307
    [No Abstract]   [Full Text] [Related]  

  • 9. Last word on viewpoint: Perspective on the future use of genomics in exercise prescription.
    Roth SM
    J Appl Physiol (1985); 2008 Apr; 104(4):1254. PubMed ID: 18385309
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspective on the future use of genomics in exercise prescription.
    Roth SM
    J Appl Physiol (1985); 2008 Apr; 104(4):1243-5. PubMed ID: 18048588
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Higashi Y
    J Appl Physiol (1985); 2008 Aug; 105(2):770. PubMed ID: 18678633
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Wagner PD
    J Appl Physiol (1985); 2008 Aug; 105(2):774. PubMed ID: 18678637
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Leicht AS; Tulppo MP; Golledge J
    J Appl Physiol (1985); 2008 Aug; 105(2):775. PubMed ID: 18678638
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise? Habitual exercise and vascular function.
    Barnes JN; Tanaka H
    J Appl Physiol (1985); 2008 Aug; 105(2):777. PubMed ID: 18678640
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Iwamoto GA; Nelson AJ
    J Appl Physiol (1985); 2008 Aug; 105(2):773. PubMed ID: 18678636
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise? Enhanced vascular function: a rationale for exercise and marker of cardiovascular health.
    Elliott M
    J Appl Physiol (1985); 2008 Aug; 105(2):776. PubMed ID: 18678639
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Gielen S; Hambrecht R; Schuler GC
    J Appl Physiol (1985); 2008 Aug; 105(2):771. PubMed ID: 18678634
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise?
    Reid JJ; Hawley JA
    J Appl Physiol (1985); 2008 Aug; 105(2):772. PubMed ID: 18678635
    [No Abstract]   [Full Text] [Related]  

  • 19. Submaximal markers of exercise intensity.
    Hills AP; Byrne NM; Ramage AJ
    J Sports Sci; 1998 Jan; 16 Suppl():S71-6. PubMed ID: 22587719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on Viewpoint: Exercise and cardiovascular risk reduction: time to update the rationale for exercise? Considering the role of sex in modulating direct effects of exercise on the vasculature.
    Parker B; Proctor D
    J Appl Physiol (1985); 2008 Aug; 105(2):778. PubMed ID: 18678641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.